The effect of TNF*B gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls

European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics
C E WhichelowJ A Sachs

Abstract

TNF-alpha and -beta have been implicated in the development of HLA-associated autoimmune diseases. It has been suggested that inter-individual differences in the secretion levels of these cytokines may contribute to the predisposition of certain individuals to the development of diseases such as insulin-dependent diabetes mellitus (IDDM). We have investigated whether a diallelic TNF*B polymorphism detected using the enzyme Ncol influences the TNF-alpha and/or -beta secretory capacity of peripheral blood mononuclear cells (PBMC) from PHA stimulated healthy individuals and IDDM patients. We have shown that the level of TNF-beta secreted correlates with the TNF*B genotype in healthy individuals: those with the TNF B*2 allele secreted significantly higher levels of TNF-beta (P = 0.025) than those with the TNF*B1 allele. In IDDM patients, the reverse situation was observed, with those patients with the TNF*B1 allele secreting higher levels of TNF-beta than those with the TNF*B2 allele. No correlation was found between TNF-alpha levels and TNF*B genotype. Furthermore, when IDDM patients and controls were matched for TNF*B genotype, the IDDM patients with the TNF*B2 allele secreted significantly lower levels of TNF-beta than controls ...Continue Reading

References

Mar 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·L M KunkelJ M Rary
Apr 1, 1990·Immunology Today·J A Todd
Jan 28, 1988·Nature·C O Jacob, H O McDevitt
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·T SpiesJ L Strominger
Oct 25, 1985·Nucleic Acids Research·K C Reed, D A Mann
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·B D WilliamsonL J Old
Aug 1, 1984·The Journal of Clinical Investigation·D RaumK H Gabbay

❮ Previous
Next ❯

Citations

Mar 7, 2001·Arthritis and Rheumatism·J TuokkoJ Ilonen
Nov 16, 2013·Biochemical Genetics·Mouna StayoussefTouhami Mahjoub
Apr 2, 2005·Breast Cancer Research and Treatment·Kyoung-Mu LeeDaehee Kang
Mar 20, 1999·Transplantation Proceedings·N A HaldarK I Welsh
Oct 20, 2001·Diabetes Research and Clinical Practice·G KumaramanickavelL Gopal
Jun 30, 2004·Mediators of Inflammation·Joanna BaldingOwen P Smith
Aug 26, 2006·Cytokine·Suk-Kyun YangKyuyoung Song
Oct 19, 2006·Mediators of Inflammation·Grazyna DejaEwa Małecka-Tendera
Aug 24, 1999·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·A N AbdallahA Iron
Mar 31, 2004·Nature Genetics·Julian C KnightDominic P Kwiatkowski
Jul 22, 2004·European Journal of Human Genetics : EJHG·UNKNOWN PROCARDIS Consortium
Oct 5, 2006·Current Opinion in Anaesthesiology·Frank Stüber, Andreas Hoeft
Apr 24, 2003·Archives of Dermatological Research·Tai-Gyu KimTae-Yoon Kim
Jul 1, 1998·Blood Cells, Molecules & Diseases·B Beutler, F Bazzoni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.